ARTICLE | Clinical News
Rolofylline: Development discontinued
August 10, 2009 7:00 AM UTC
Merck discontinued development of rolofylline after announcing in June that the compound missed the primary and secondary endpoints in the international Phase III PROTECT trial (see BioCentury, June 8...